Infini Capital Management LTD I Mab Transaction History
Infini Capital Management LTD
- $21.7 Million
- Q3 2023
Shares
2 transactions
Others Institutions Holding IMAB
# of Institutions
40Shares Held
15.6MCall Options Held
3KPut Options Held
1.9K-
Hhlr Advisors, Ltd. Grand Cayman, E96.91MShares$7.81 Million0.3% of portfolio
-
Decheng Capital Management Iii (Cayman), LLC4.17MShares$4.71 Million3.04% of portfolio
-
Boothbay Fund Management, LLC New York, NY1.38MShares$1.56 Million0.07% of portfolio
-
David A. Siegel Two Sigma Advisers, LP | New York, Ny577KShares$651,5570.0% of portfolio
-
Two Sigma Investments, LP New York, NY478KShares$540,6390.0% of portfolio
About I-Mab
- Ticker IMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,098,800
- Market Cap $93.9M
- Description
- I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...